Kintor Pharmaceutical Limited

SEHK:9939 Stok Raporu

Piyasa değeri: HK$463.3m

Kintor Pharmaceutical Temettü

Temettü kriter kontrolleri 0/6

Kintor Pharmaceutical does not have a record of paying a dividend.

Anahtar bilgiler

n/a

Temettü verimi

-0.1%

Geri Alım Getirisi

Toplam Hissedar Getirisi-0.1%
Gelecekteki Temettü Verimi0%
Temettü Büyümesin/a
Bir sonraki temettü ödeme tarihin/a
Eski temettü tarihin/a
Hisse başına temettün/a
Ödeme oranın/a

Son temettü güncellemeleri

Güncelleme yok

Recent updates

Is Kintor Pharmaceutical (HKG:9939) Using Debt In A Risky Way?

Oct 07
Is Kintor Pharmaceutical (HKG:9939) Using Debt In A Risky Way?

Does Kintor Pharmaceutical (HKG:9939) Have A Healthy Balance Sheet?

Nov 16
Does Kintor Pharmaceutical (HKG:9939) Have A Healthy Balance Sheet?

Does Kintor Pharmaceutical (HKG:9939) Have A Healthy Balance Sheet?

Apr 28
Does Kintor Pharmaceutical (HKG:9939) Have A Healthy Balance Sheet?

Does Kintor Pharmaceutical (HKG:9939) Have A Healthy Balance Sheet?

Dec 06
Does Kintor Pharmaceutical (HKG:9939) Have A Healthy Balance Sheet?

Is Kintor Pharmaceutical (HKG:9939) Using Debt Sensibly?

Sep 01
Is Kintor Pharmaceutical (HKG:9939) Using Debt Sensibly?

Kintor Pharmaceutical Limited (HKG:9939) Insiders Increased Their Holdings

Feb 17
Kintor Pharmaceutical Limited (HKG:9939) Insiders Increased Their Holdings

What Kind Of Investors Own Most Of Kintor Pharmaceutical Limited (HKG:9939)?

Dec 23
What Kind Of Investors Own Most Of Kintor Pharmaceutical Limited (HKG:9939)?

Ödemelerde İstikrar ve Büyüme

Temettü verilerini getirme

İstikrarlı Temettü: Insufficient data to determine if 9939's dividends per share have been stable in the past.

Büyüyen Temettü: Insufficient data to determine if 9939's dividend payments have been increasing.


Piyasaya Karşı Temettü Getirisi

Kintor Pharmaceutical Piyasaya Karşı Temettü Getirisi
9939 temettü verimi piyasa ile karşılaştırıldığında nasıldır?
SegmentTemettü Verimi
Şirket (9939)n/a
Pazarın Alt %25'i (HK)3.2%
Pazarın En İyi %25'i (HK)7.9%
Sektör Ortalaması (Biotechs)1.1%
Analist tahmini (9939) (3 yıla kadar)0%

Önemli Temettü: Unable to evaluate 9939's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

Yüksek Temettü: Unable to evaluate 9939's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Hissedarlara Ödenen Kazanç

Kazanç Kapsamı: Insufficient data to calculate 9939's payout ratio to determine if its dividend payments are covered by earnings.


Hissedarlara Nakit Ödeme

Nakit Akışı Kapsamı: Unable to calculate sustainability of dividends as 9939 has not reported any payouts.


Güçlü temettü ödeyen şirketleri keşfedin